Last 12 months
Inside the activity.
0 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 28, 2022 Filed Mar 2, 2022 19:10 UTC |
Leal JamesSVP, Operations
|
Exercise / conversionCommon Stock | 310 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-22-000025 · wf-form4_164626619341736.xml · nonDerivative · entry 1 Leal James · CIK 0001866570 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,318 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2022 Filed Mar 3, 2022 00:04 UTC |
Gasser Elizabeth AnneEVP, Chief Strategy Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 372 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-22-000023 · wf-form4_164626585574888.xml · derivative · entry 3 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,354 Underlying: Common Stock · 372 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan). F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of the Company. F4 · derivative.exercise_date: RSU vested as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. F4 · derivative.expiration_date: RSU vested as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. Read SEC document |
| February 28, 2022 Filed Mar 3, 2022 00:04 UTC |
Gasser Elizabeth AnneEVP, Chief Strategy Officer
|
Tax withholdingCommon Stock | 153 | $112.43 | $17,201.79 |
DisclosureSEC source: 0001438133-22-000023 · wf-form4_164626585574888.xml · nonDerivative · entry 2 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 650 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| February 28, 2022 Filed Mar 3, 2022 00:04 UTC |
Gasser Elizabeth AnneEVP, Chief Strategy Officer
|
Exercise / conversionCommon Stock | 372 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-22-000023 · wf-form4_164626585574888.xml · nonDerivative · entry 1 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 803 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2022 Filed Mar 3, 2022 00:21 UTC |
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
|
Exercise / conversionRestricted Stock Unit · Derivative | 407 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-22-000029 · wf-form4_164626689642665.xml · derivative · entry 4 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,658 Underlying: Common Stock · 407 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan). F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of the Company. F5 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. F5 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. Read SEC document |
| February 28, 2022 Filed Mar 3, 2022 00:21 UTC |
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
|
Tax withholdingCommon Stock | 138 | $112.43 | $15,515.34 |
DisclosureSEC source: 0001438133-22-000029 · wf-form4_164626689642665.xml · nonDerivative · entry 2 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,618 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| February 28, 2022 Filed Mar 3, 2022 00:21 UTC |
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
|
Exercise / conversionCommon Stock | 407 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-22-000029 · wf-form4_164626689642665.xml · nonDerivative · entry 1 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,756 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2022 Filed Mar 3, 2022 00:32 UTC |
BERGER DAVID BEVP & Chief Operating Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 407 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-22-000035 · wf-form4_164626752716756.xml · derivative · entry 6 BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,658 Underlying: Common Stock · 407 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan). F6 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of the Company. F7 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. F7 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. Read SEC document |
| February 28, 2022 Filed Mar 3, 2022 00:32 UTC |
BERGER DAVID BEVP & Chief Operating Officer
|
Tax withholdingCommon Stock | 141 | $112.43 | $15,852.63 |
DisclosureSEC source: 0001438133-22-000035 · wf-form4_164626752716756.xml · nonDerivative · entry 2 BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,717 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| February 28, 2022 Filed Mar 3, 2022 00:32 UTC |
BERGER DAVID BEVP & Chief Operating Officer
|
Exercise / conversionCommon Stock | 407 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-22-000035 · wf-form4_164626752716756.xml · nonDerivative · entry 1 BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,858 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2022 Filed Mar 3, 2022 00:29 UTC |
Morrison SusanEVP & Chief Admin. Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 407 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-22-000033 · wf-form4_164626735750494.xml · derivative · entry 3 Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,658 Underlying: Common Stock · 407 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan). F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of the Company. F4 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. F4 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. Read SEC document |
| February 28, 2022 Filed Mar 3, 2022 00:29 UTC |
Morrison SusanEVP & Chief Admin. Officer
|
Tax withholdingCommon Stock | 114 | $112.43 | $12,817.02 |
DisclosureSEC source: 0001438133-22-000033 · wf-form4_164626735750494.xml · nonDerivative · entry 2 Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,606 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| February 28, 2022 Filed Mar 3, 2022 00:29 UTC |
Morrison SusanEVP & Chief Admin. Officer
|
Exercise / conversionCommon Stock | 407 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-22-000033 · wf-form4_164626735750494.xml · nonDerivative · entry 1 Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,720 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2022 Filed Mar 3, 2022 00:25 UTC |
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
|
Exercise / conversionRestricted Stock Unit · Derivative | 407 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-22-000031 · wf-form4_164626708325879.xml · derivative · entry 3 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,658 Underlying: Common Stock · 407 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan). F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of the Company. F4 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. F4 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. Read SEC document |
| February 28, 2022 Filed Mar 3, 2022 00:25 UTC |
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
|
Tax withholdingCommon Stock | 146 | $112.43 | $16,414.78 |
DisclosureSEC source: 0001438133-22-000031 · wf-form4_164626708325879.xml · nonDerivative · entry 2 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,807 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| February 28, 2022 Filed Mar 3, 2022 00:25 UTC |
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
|
Exercise / conversionCommon Stock | 407 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-22-000031 · wf-form4_164626708325879.xml · nonDerivative · entry 1 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,953 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2022 Filed Mar 3, 2022 00:16 UTC |
Sheridan John FDirector · PRESIDENT & CEO
|
Exercise / conversionRestricted Stock Unit · Derivative | 819 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-22-000027 · wf-form4_164626653879531.xml · derivative · entry 3 Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,378 Underlying: Common Stock · 819 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan). F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of the Company. F4 · derivative.exercise_date: RSU vested as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. F4 · derivative.expiration_date: RSU vested as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. Read SEC document |
| February 28, 2022 Filed Mar 3, 2022 00:16 UTC |
Sheridan John FDirector · PRESIDENT & CEO
|
Tax withholdingCommon Stock | 284 | $112.43 | $31,930.12 |
DisclosureSEC source: 0001438133-22-000027 · wf-form4_164626653879531.xml · nonDerivative · entry 2 Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,558 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| February 28, 2022 Filed Mar 3, 2022 00:16 UTC |
Sheridan John FDirector · PRESIDENT & CEO
|
Exercise / conversionCommon Stock | 819 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-22-000027 · wf-form4_164626653879531.xml · nonDerivative · entry 1 Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,842 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2022 Filed Feb 18, 2022 00:18 UTC |
Hansen Shannon MarieSVP & General Counsel
|
GrantRestricted Stock Unit · Derivative | 8,492 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-22-000016 · wf-form4_164514347536421.xml · derivative · entry 1 Hansen Shannon Marie · CIK 0001908267 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,492 Underlying: Common Stock · 8,492 shares Expires not disclosed F1 · security: Awarded on February 15, 2022 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the Company. F3 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one-year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. F3 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one-year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 21:28 UTC |
ROBERTSON REBECCA BDirector
|
Exercise / conversionStock Option · Derivative | 1,500 | $34.00 Strike: $34.00 | $51,000.00 |
DisclosureSEC source: 0001438133-22-000010 · wf-form4_164392367063084.xml · derivative · entry 5 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,392 Underlying: Common Stock · 1,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option shall vest in 36 equal monthly installments from January 2, 2019, subject to the terms of Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). F7 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 21:28 UTC |
ROBERTSON REBECCA BDirector
|
SaleCommon Stock | 533 | $118.82 | $63,331.06 |
DisclosureSEC source: 0001438133-22-000010 · wf-form4_164392367063084.xml · nonDerivative · entry 4 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 26, 2021. F5 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $118.52 to $119.50. The Reporting Person undertakes to provide the SEC, the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 21:28 UTC |
ROBERTSON REBECCA BDirector
|
SaleCommon Stock | 667 | $117.89 | $78,632.63 |
DisclosureSEC source: 0001438133-22-000010 · wf-form4_164392367063084.xml · nonDerivative · entry 3 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 533 F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 26, 2021. F4 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $117.46 to $118.29. The Reporting Person undertakes to provide the SEC, the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 21:28 UTC |
ROBERTSON REBECCA BDirector
|
SaleCommon Stock | 300 | $116.63 | $34,989.00 |
DisclosureSEC source: 0001438133-22-000010 · wf-form4_164392367063084.xml · nonDerivative · entry 2 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,200 F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 26, 2021. F3 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $116.33 to $116.99. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 21:28 UTC |
ROBERTSON REBECCA BDirector
|
Exercise / conversionCommon Stock | 1,500 | $34.00 | $51,000.00 |
DisclosureSEC source: 0001438133-22-000010 · wf-form4_164392367063084.xml · nonDerivative · entry 1 ROBERTSON REBECCA B · CIK 0001201585 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 21:23 UTC |
BERGER DAVID BEVP, Bus Ops & Compliance
|
Exercise / conversionStock Option · Derivative | 1,000 | $18.86 Strike: $18.86 | $18,860.00 |
DisclosureSEC source: 0001438133-22-000008 · wf-form4_164392338173286.xml · derivative · entry 6 BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,000 Underlying: Common Stock · 1,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The options vested as to fifty (50%) of the underlying shares on 6/14/2019, and the remaining shares vested in twelve (12) equal monthly installments thereafter, subject to the terms of Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). F8 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 21:23 UTC |
BERGER DAVID BEVP, Bus Ops & Compliance
|
SaleCommon Stock | 358 | $118.89 | $42,562.62 |
DisclosureSEC source: 0001438133-22-000008 · wf-form4_164392338173286.xml · nonDerivative · entry 4 BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,451 F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2021. F5 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $118.52 to $119.04. The Reporting Person undertakes to provide the SEC, the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 21:23 UTC |
BERGER DAVID BEVP, Bus Ops & Compliance
|
SaleCommon Stock | 400 | $117.78 | $47,112.00 |
DisclosureSEC source: 0001438133-22-000008 · wf-form4_164392338173286.xml · nonDerivative · entry 3 BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,809 F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2021. F4 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $117.46 to $118.12. The Reporting Person undertakes to provide the SEC, the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 21:23 UTC |
BERGER DAVID BEVP, Bus Ops & Compliance
|
SaleCommon Stock | 242 | $116.67 | $28,234.14 |
DisclosureSEC source: 0001438133-22-000008 · wf-form4_164392338173286.xml · nonDerivative · entry 2 BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,209 F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2021. F3 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $116.36 to $116.99. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 21:23 UTC |
BERGER DAVID BEVP, Bus Ops & Compliance
|
Exercise / conversionCommon Stock | 1,000 | $18.86 | $18,860.00 |
DisclosureSEC source: 0001438133-22-000008 · wf-form4_164392338173286.xml · nonDerivative · entry 1 BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,451 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| January 04, 2022 Filed Jan 6, 2022 00:17 UTC |
Sodhi RajwantDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,069 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-22-000004 · wf-form4_164142826221175.xml · derivative · entry 2 Sodhi Rajwant · CIK 0001715325 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,139 Underlying: Common Stock · 1,069 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the Company. F3 · kind: This RSU award was granted on January 4, 2021. 33% of the RSU vested on January 4, 2022 and the remaining 67% will vest annually over the next two years. F4 · derivative.exercise_date: The total number of shares subject to the RSU will vest over a period of three years in equal annual installments on the anniversary of the grant, subject to the terms of the 2013 Plan. F4 · derivative.expiration_date: The total number of shares subject to the RSU will vest over a period of three years in equal annual installments on the anniversary of the grant, subject to the terms of the 2013 Plan. Read SEC document |
| January 04, 2022 Filed Jan 6, 2022 00:17 UTC |
Sodhi RajwantDirector
|
Exercise / conversionCommon Stock | 1,069 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-22-000004 · wf-form4_164142826221175.xml · nonDerivative · entry 1 Sodhi Rajwant · CIK 0001715325 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,069 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2022 Filed Jan 6, 2022 00:12 UTC |
BERGER DAVID BEVP, Bus Ops & Compliance
|
Exercise / conversionStock Option · Derivative | 1,000 | $18.86 Strike: $18.86 | $18,860.00 |
DisclosureSEC source: 0001438133-22-000002 · wf-form4_164142796642696.xml · derivative · entry 5 BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 1,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The options vested as to fifty (50%) of the underlying shares on 6/14/2019, and the remaining shares vested in twelve (12) equal monthly installments thereafter, subject to the terms of Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). F7 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| January 03, 2022 Filed Jan 6, 2022 00:12 UTC |
BERGER DAVID BEVP, Bus Ops & Compliance
|
SaleCommon Stock | 170 | $150.40 | $25,568.00 |
DisclosureSEC source: 0001438133-22-000002 · wf-form4_164142796642696.xml · nonDerivative · entry 3 BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,451 F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2021. F4 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $150.31 to $150.52. The Reporting Person undertakes to provide the SEC, the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| January 03, 2022 Filed Jan 6, 2022 00:12 UTC |
BERGER DAVID BEVP, Bus Ops & Compliance
|
SaleCommon Stock | 830 | $148.91 | $123,595.30 |
DisclosureSEC source: 0001438133-22-000002 · wf-form4_164142796642696.xml · nonDerivative · entry 2 BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,621 F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2021. F3 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $148.78 to $149.26. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| January 03, 2022 Filed Jan 6, 2022 00:12 UTC |
BERGER DAVID BEVP, Bus Ops & Compliance
|
Exercise / conversionCommon Stock | 1,000 | $18.86 | $18,860.00 |
DisclosureSEC source: 0001438133-22-000002 · wf-form4_164142796642696.xml · nonDerivative · entry 1 BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,451 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| December 27, 2021 Filed Dec 29, 2021 16:29 UTC |
Leal JamesSVP, Operations
|
Exercise / conversionStock Option · Derivative | 239 | $82.34 Strike: $82.34 | $19,679.26 |
DisclosureSEC source: 0001438133-21-000232 · wf-form4_164081333996082.xml · derivative · entry 7 Leal James · CIK 0001866570 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,909 Underlying: Common Stock · 239 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The options vested as to twenty-five (25%) of the underlying shares on 5/27/2021, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the 2013 Plan. F6 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| December 27, 2021 Filed Dec 29, 2021 16:29 UTC |
Leal JamesSVP, Operations
|
Exercise / conversionStock Option · Derivative | 1,667 | $51.50 Strike: $51.50 | $85,850.50 |
DisclosureSEC source: 0001438133-21-000232 · wf-form4_164081333996082.xml · derivative · entry 6 Leal James · CIK 0001866570 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,333 Underlying: Common Stock · 1,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The options vested as to twenty-five (25%) of the underlying shares on 2/15/2020, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the terms of the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). F6 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| December 27, 2021 Filed Dec 29, 2021 16:29 UTC |
Leal JamesSVP, Operations
|
SaleCommon Stock | 100 | $152.27 | $15,227.00 |
DisclosureSEC source: 0001438133-21-000232 · wf-form4_164081333996082.xml · nonDerivative · entry 5 Leal James · CIK 0001866570 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,008 F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2020. Read SEC document |
| December 27, 2021 Filed Dec 29, 2021 16:29 UTC |
Leal JamesSVP, Operations
|
SaleCommon Stock | 1,266 | $151.60 | $191,925.60 |
DisclosureSEC source: 0001438133-21-000232 · wf-form4_164081333996082.xml · nonDerivative · entry 4 Leal James · CIK 0001866570 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,108 F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2020. F4 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $151.26 to $152.09.The Reporting Person undertakes to provide the SEC, the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| December 27, 2021 Filed Dec 29, 2021 16:29 UTC |
Leal JamesSVP, Operations
|
SaleCommon Stock | 540 | $150.95 | $81,513.00 |
DisclosureSEC source: 0001438133-21-000232 · wf-form4_164081333996082.xml · nonDerivative · entry 3 Leal James · CIK 0001866570 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,374 F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2020. F3 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $150.25 to $151.21. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| December 27, 2021 Filed Dec 29, 2021 16:29 UTC |
Leal JamesSVP, Operations
|
Exercise / conversionCommon Stock | 239 | $82.34 | $19,679.26 |
DisclosureSEC source: 0001438133-21-000232 · wf-form4_164081333996082.xml · nonDerivative · entry 2 Leal James · CIK 0001866570 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,914 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| December 27, 2021 Filed Dec 29, 2021 16:29 UTC |
Leal JamesSVP, Operations
|
Exercise / conversionCommon Stock | 1,667 | $51.50 | $85,850.50 |
DisclosureSEC source: 0001438133-21-000232 · wf-form4_164081333996082.xml · nonDerivative · entry 1 Leal James · CIK 0001866570 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,675 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| December 27, 2021 Filed Dec 29, 2021 21:42 UTC |
Gasser Elizabeth AnneEVP, Chief Strategy Officer
|
Exercise / conversionStock Option · Derivative | 287 | $82.34 Strike: $82.34 | $23,631.58 |
DisclosureSEC source: 0001438133-21-000234 · wf-form4_164081416451425.xml · derivative · entry 6 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,314 Underlying: Common Stock · 287 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The options vested as to twenty-five (25%) of the underlying shares on 5/27/2021, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the 2013 Plan. F6 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| December 27, 2021 Filed Dec 29, 2021 21:42 UTC |
Gasser Elizabeth AnneEVP, Chief Strategy Officer
|
Exercise / conversionStock Option · Derivative | 797 | $89.54 Strike: $89.54 | $71,363.38 |
DisclosureSEC source: 0001438133-21-000234 · wf-form4_164081416451425.xml · derivative · entry 5 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,717 Underlying: Common Stock · 797 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The options vested as to twenty-five (25%) of the underlying shares on 2/18/2021, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the terms of Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). F6 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| December 27, 2021 Filed Dec 29, 2021 21:42 UTC |
Gasser Elizabeth AnneEVP, Chief Strategy Officer
|
SaleCommon Stock | 714 | $151.63 | $108,263.82 |
DisclosureSEC source: 0001438133-21-000234 · wf-form4_164081416451425.xml · nonDerivative · entry 4 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 431 F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2021. F4 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $151.26 to $151.99. The Reporting Person undertakes to provide the SEC, the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| December 27, 2021 Filed Dec 29, 2021 21:42 UTC |
Gasser Elizabeth AnneEVP, Chief Strategy Officer
|
SaleCommon Stock | 370 | $150.84 | $55,810.80 |
DisclosureSEC source: 0001438133-21-000234 · wf-form4_164081416451425.xml · nonDerivative · entry 3 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,145 F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2021. F3 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $150.25 to $151.21. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| December 27, 2021 Filed Dec 29, 2021 21:42 UTC |
Gasser Elizabeth AnneEVP, Chief Strategy Officer
|
Exercise / conversionCommon Stock | 287 | $82.34 | $23,631.58 |
DisclosureSEC source: 0001438133-21-000234 · wf-form4_164081416451425.xml · nonDerivative · entry 2 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,515 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| December 27, 2021 Filed Dec 29, 2021 21:42 UTC |
Gasser Elizabeth AnneEVP, Chief Strategy Officer
|
Exercise / conversionCommon Stock | 797 | $89.54 | $71,363.38 |
DisclosureSEC source: 0001438133-21-000234 · wf-form4_164081416451425.xml · nonDerivative · entry 1 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,228 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 22:35 UTC |
BERGER DAVID BEVP, Bus Ops & Compliance
|
Exercise / conversionStock Option · Derivative | 12,000 | $18.86 Strike: $18.86 | $226,320.00 |
DisclosureSEC source: 0001438133-21-000230 · wf-form4_163978050072248.xml · derivative · entry 4 BERGER DAVID B · CIK 0001422126 · EVP, Bus Ops & Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,000 Underlying: Common Stock · 12,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The options vested as to fifty (50%) of the underlying shares on 6/14/2019, and the remaining shares vested in twelve (12) equal monthly installments thereafter, subject to the terms of Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). F5 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.